Modified Dialectical Behavior Therapy for Treating Anxiety and Depression
Official title: Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders in Two Medical Centers: a Randomized Controlled Trial
Run by Mackay Memorial Hospital · NCT05989451 · Data updated 2026-11-12
This study is testing a new type of therapy called modified Dialectical Behavior Therapy to see if it can help people with anxiety and depression feel better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Mackay Memorial Hospital Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | July 2026 |
| Study ends | October 2026 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT05989451 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are Mandarin-speaking individuals currently diagnosed with anxiety or depressive disorders.
✕Probably not a fit
Patients with intellectual disabilities, substance use disorders, or severe mental health conditions such as bipolar or psychotic disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the efficacy of a modified Dialectical Behavior Therapy (DBT) intervention for the transdiagnostic treatment of anxiety and depressive disorders. Conducted over three years, the study will involve a randomized controlled design with two parallel groups at two medical centers in Taiwan. Participants will receive 12 weekly individual therapy sessions, and their clinical outcomes will be assessed before, after, and three months post-intervention. The goal is to determine whether this modified DBT approach can improve the severity of emotional disorders and enhance overall quality of life.
Why it matters
Potential benefit: If successful, this intervention could significantly improve treatment outcomes for patients suffering from anxiety and depressive disorders.
How similar studies have gone: Preliminary studies on transdiagnostic psychotherapy approaches, including DBT, have shown encouraging results, suggesting potential for success in this novel application.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Mandarin Chinese-language proficiency sufficient to complete the study questionnaire 2. A current diagnosis of depressive or anxiety disorder as diagnosed from a SCAN interview Exclusion Criteria: 1. Intellectual disability 2. Substance use disorder in the past three months 3. Bipolar disorder 4. Psychotic disorder 5. Organic brain disorder 6. Acute suicidality or a history of frequent or recent suicide attempts 7. Recent (past six weeks) change in psychiatric medication or unwillingness to maintain a stable dosage of medication during study participation 8. Had received five or more sessions of CBT in the past five years or was unwilling to stop concurrent psychotherapy for an emotional disorder 9. Any mental or physical condition requiring hospital admission 10. Another medical condition likely to prevent participation in the study As we also aim for a naturalistic setting, we do not exclude patients who undergo a medication change during the trial if this is judged necessary or clinically important by the treating clinician. Instead, we include a question about this in the questionnaire to the referring/treating clinician.
Where it's running
-
MacKay Memorial Hospital
Taipei, Taiwan Recruiting
Study contacts
- Principal investigator: Shen-Ing Liu, Ph.D — Mackay Memorial Hospital
- Study coordinator: Hui-Chun Huang, Ph.D
- Email: aihch@mmh.org.tw
- Phone: 886-2-28094661
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Community Connections for treating emotional disorders in youth
This study is testing a new therapy program for kids and teens with anxiety and depression to see if it helps them feel better, and it involves both the youth and their parents.
-
Understanding anxiety, depression, and bipolar disorder over time in China
This study tests how anxiety, depressive, and bipolar symptoms change over three years to find patterns that help with earlier recognition and prediction in people aged 12–55.
-
Aerobic Exercise as an Adjunct Therapy for Depression
This study tests whether adding a structured aerobic exercise program to standard antidepressant and therapy helps reduce depression severity more than standard care alone.
-
Group Unified Protocol for Emotional Disorders in adults in public mental health (UP in Spanish)
A group-based Spanish version of the Unified Protocol is being tested with adults in public mental health to see if it helps anxiety, depression, and related symptoms.
-
Metformin added to antidepressants for depression with obesity in Pakistani adults
This study tests whether adding metformin to antidepressant therapy helps reduce depressive symptoms and BMI in adults with depression and overweight/obesity in Pakistan.
-
Parent group program using the Unified Protocol for teens with autism and anxiety/depression
This trial tests a parent-guided adaptation of the Unified Protocol to help adolescents with autism and co-occurring anxiety or depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.